PROVIDER PROFILE · NPI 1013412840

Fadi Adel

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

157

Beneficiaries

—

Total drug cost

$63K

Distinct drugs

Brand share

54.8%

Top prescribed drugs

Apixaban18 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (3)

Hospital

Hospital

Hospital

CROSS-REFERENCE